Chong H, Vile R G
Imperial Cancer Research Fund Laboratory of Cancer Gene Therapy, Rayne Institute, St Thomas' Hospital, London, UK.
Gene Ther. 1996 Jul;3(7):624-9.
We report the discovery, on routine screening, of a replication-competent retrovirus (RCR) produced from a third generation amphotropic packaging cell line, GP + envAM12. In this line, the gag-pol and env helper genes are located on separate plasmids to minimise the chances of recombination events that may lead to RCR formation. Plasmid pBabeNeo was transfected into GP + envAM12 to obtain a producer line. Supernatant from this line was used to infect two lines, B16 and 1735-puro, and stable colonies which were obtained were pooled. Supernatants from both these lines were able to transfer the neo gene to fresh cells through several passages, indicating the presence of helper virus. Rescue of puro from 1735-puro cells, which contain the pBabePuro provirus, was also achieved. Mobilisation of lacZ from TELCeB6 cells, which contain the MFGnlslacZ provirus, was also possible. The RCR was able to transfer lacZ to ampli-GPE cells, an ecotropic packaging cell line, but transfer to fresh GP + envAM12 cells was minimal, demonstrating receptor interference of the RCR by the amphotropic envelope. These observations strongly suggest that a RCR with an amphotropic envelope arose in the GP + envAM12-pBabeNeo producer line. To our knowledge, this is the first report of RCR arising from routine use of GP + envAM12 cells or any similar third generation packaging line and has important implications for the use of such lines in human gene therapy protocols.
我们报告了在常规筛选中发现的一种由第三代嗜异性包装细胞系GP + envAM12产生的具有复制能力的逆转录病毒(RCR)。在该细胞系中,gag-pol和env辅助基因位于不同的质粒上,以尽量减少可能导致RCR形成的重组事件的发生几率。将质粒pBabeNeo转染到GP + envAM12中以获得一个生产细胞系。该细胞系的上清液用于感染两个细胞系B16和1735-puro,并将获得的稳定菌落进行合并。这两个细胞系的上清液都能够通过多次传代将neo基因转移到新鲜细胞中,表明存在辅助病毒。从含有pBabePuro前病毒的1735-puro细胞中也成功拯救出了puro。从含有MFGnlslacZ前病毒的TELCeB6细胞中也成功实现了lacZ的转移。该RCR能够将lacZ转移到嗜亲性包装细胞系ampli-GPE细胞中,但转移到新鲜的GP + envAM12细胞中的情况极少,这表明嗜异性包膜对RCR存在受体干扰。这些观察结果强烈表明,在GP + envAM12-pBabeNeo生产细胞系中出现了一种具有嗜异性包膜的RCR。据我们所知,这是关于因常规使用GP + envAM12细胞或任何类似的第三代包装细胞系而产生RCR的首次报告,对在人类基因治疗方案中使用此类细胞系具有重要意义。